Sign in
4/A

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-22-032677

Chief Medical Officer acquired 170,354 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Smith Karen L. · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-05-19 Grant or award : show line 1 in the form +170,354 194,690 D
Loading xslF345X03/doc4a.xml…